These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 32870235)
1. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval. Thomson K; Nachlis H JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235 [No Abstract] [Full Text] [Related]
2. Drug Evaluation during the Covid-19 Pandemic. Rome BN; Avorn J N Engl J Med; 2020 Jun; 382(24):2282-2284. PubMed ID: 32289216 [No Abstract] [Full Text] [Related]
3. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times. Collins FS; Stoffels P JAMA; 2020 Jun; 323(24):2455-2457. PubMed ID: 32421150 [No Abstract] [Full Text] [Related]
4. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment? Patrì A; Fabbrocini G J Am Acad Dermatol; 2020 Jun; 82(6):e221. PubMed ID: 32283237 [No Abstract] [Full Text] [Related]
5. Does hydroxychloroquine combat COVID-19? A timeline of evidence. Alia E; Grant-Kels JM J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236 [No Abstract] [Full Text] [Related]
7. Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval. Avorn J; Kesselheim AS N Engl J Med; 2020 Oct; 383(18):1706-1708. PubMed ID: 32931162 [No Abstract] [Full Text] [Related]
8. Beat COVID-19 through innovation. Azoulay P; Jones B Science; 2020 May; 368(6491):553. PubMed ID: 32381693 [No Abstract] [Full Text] [Related]
10. Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies. Zhai MZ; Lye CT; Kesselheim AS JAMA Intern Med; 2020 Sep; 180(9):1145-1146. PubMed ID: 32427277 [No Abstract] [Full Text] [Related]
11. Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use. Edwards KM; Orenstein WA J Pediatr; 2020 Sep; 224():124-128. PubMed ID: 32565096 [No Abstract] [Full Text] [Related]
12. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19. Piszczatoski CR; Powell J Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025 [TBL] [Abstract][Full Text] [Related]
13. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19. Principi N; Esposito S Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322 [No Abstract] [Full Text] [Related]
14. The race against COVID-19. Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704 [No Abstract] [Full Text] [Related]
15. SARS-CoV-2: a time for clear and immediate action. Poland GA Lancet Infect Dis; 2020 May; 20(5):531-532. PubMed ID: 32243818 [No Abstract] [Full Text] [Related]
16. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336 [No Abstract] [Full Text] [Related]
17. Hydroxychloroquine prophylaxis for COVID-19 contacts in India. Rathi S; Ish P; Kalantri A; Kalantri S Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324 [No Abstract] [Full Text] [Related]
18. Internet Searches for Unproven COVID-19 Therapies in the United States. Liu M; Caputi TL; Dredze M; Kesselheim AS; Ayers JW JAMA Intern Med; 2020 Aug; 180(8):1116-1118. PubMed ID: 32347895 [TBL] [Abstract][Full Text] [Related]
19. Consider pregnancy in COVID-19 therapeutic drug and vaccine trials. Whitehead CL; Walker SP Lancet; 2020 May; 395(10237):e92. PubMed ID: 32410758 [No Abstract] [Full Text] [Related]